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Abstract: Bovine mycotoxicosis is a disorder caused by the ingestion of fungal toxins. It is associated 
with chronic signs, such as reduced growth rate and milk yield, and causes significant economic 
cost to the dairy industry. The mycotoxins deoxynivalenol (DON), zearalenone (ZEN), and 
fumonisin B1 (FB1) are commonly found in grain fed to cattle. Patulin (PA) is a common grass silage 
contaminant but is also found in grain. The effects of these mycotoxins on cellular function at low 
concentrations are not well understood. Using Madin–Darby bovine kidney cells we evaluated the 
cellular response to these mycotoxins, measuring cytotoxicity, de novo protein synthesis, cell 
proliferation, cell cycle analysis, and also metabolic profiling by 1H NMR spectroscopy. DON, ZEN, 
and PA induced cytotoxicity, and PA and FB1 induced a decrease in metabolic activity in surviving 
cells. DON was the only mycotoxin found to have a significant effect on the metabolic profile, with 
exposed cells showing increased cellular amino acids, lactate, 2-oxoglutarate, 3-hydroxybutyrate, 
and UDP-N-acetylglucosamine and decreased β-alanine, choline, creatine, taurine, and myo-inositol. 
Cells exposed to DON also showed reductions in protein synthesis. DON has previously been 
documented as being a ribotoxin; the results here suggest that exposure of bovine cells to DON 
causes a decrease in protein synthesis with corresponding cellular accumulation of precursors. Cell 
proliferation was also arrested without causing apoptosis. It is likely that exposure triggers hypoxic, 
hypertonic, and ribotoxic responses in bovine cells, and that these responses contribute to reduced 
productivity in exposed cattle.  
Keywords: mycotoxicosis; metabolic profiling; protein synthesis; cell cycle arrest 
Key Contribution: Low-level exposure to the mycotoxin deoxynivalenol (DON) inhibits the normal 
function and metabolism of bovine epithelial cells, inducing hypoxic, hypertonic, and ribotoxic 
stresses. Chronic exposure to subclinical doses of DON could reduce productivity in cattle.  
 
1. Introduction 
Bovine mycotoxicosis is a disorder most commonly caused by the ingestion of fungal toxins 
(mycotoxins) within feed. Though acute manifestations exist, bovine mycotoxicosis most frequently 
constitutes a range of chronic and non-specific symptoms including digestive problems, such as 
gastroenteritis, diarrhea, and depressed feed intake [1,2], reproductive problems such as ovarian 
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cycle irregularities and infertility [3,4], immunosuppression [5,6], and neurological disorders [7,8]. 
This in turn can impact productivity through reduced growth rates and milk yield [9,10], which is 
thought to confer significant economic losses to the dairy industry [11–13]. The source of the problem 
comes predominately from mold-contaminated feed such as grain and forage silage, especially 
foraged maize (Zea mays). Silage (including whole crop (grain and straw), maize and grass) is the 
main conserved forage source for dairy and beef cattle, and represents a significant source of 
mycotoxins; yet comparatively little research has been conducted into the effects of ingestion of 
mycotoxin-contaminated silage on cattle [14]. An underlying reasoning for the skewed research 
activity when it comes to mycotoxins in livestock toward monogastrics (pigs and poultry) is the 
ability of ruminants to detoxify mycotoxins in the rumen [1]. For example, the mycotoxin 
deoxynivalenol (DON) is metabolized to de-epoxy derivatives and zearalenone (ZEN) to zearalanone 
and zearalenol metabolites [15]. However, the extent of detoxification depends on the dose rate, 
rumen digestion kinetics, and the microbial community [16]. In particular, high-production dairy 
cows are offered diets (cereals and grains rich in starch) that modify the microbial community 
structure of the rumen away from fibrolytic (fiber degrading) bacteria toward starch-degrading 
organisms. Ultimately, this reduces the pH of the rumen, altering the microbial ecosystem as the 
animal approaches acidosis, substantially reducing the ability of the rumen to detoxify mycotoxins 
[15].  
A recent analysis of silage samples in southwestern England found 90% of maize samples were 
contaminated with common mycotoxins, with over 46% of those samples containing mycotoxin 
concentrations in the moderate-to-high risk categories [17,18]. The main causative agents are fungi of 
the Fusarium, Aspergillus, and Penicillium species, which together produce a range of toxins [19]. The 
ones most commonly associated with bovine sickness are aflatoxins (AF), ochratoxin (OTA), patulin 
(PA), fumonisin, particularly fumonisin B1 (FB1), and the tricothecenes ZEN and DON [1,20]. DON 
is the best known and most common contaminant of grains, and its detection in feed is commonly a 
marker for the presence of other toxins [21]. Recent surveys of raw feed samples globally found that 
59% were contaminated with an average level of 1 mg/kg and a maximum level of 49 mg/kg of DON, 
suggesting a high likelihood of significant exposure across the life-course for most ruminants [22]. 
The effects of mycotoxins and their metabolites on several bovine cell and tissue types, such as their 
ruminal microbiota [23], monocytes [24], or ovarian cells [25,26], have been characterized and have 
contributed to our understanding of how their ingestion may cause the above-described pathologies. 
In this work, the impact of the commonly ingested mycotoxins, DON, ZEN, FB1, and PA, on a bovine 
kidney epithelial cell line (Madin–Darby bovine kidney; MDBK) were investigated. The effects of 
these mycotoxins on cellular division, protein synthesis, and metabolism were studied to gain insight 
on how these toxins might affect epithelial and specifically kidney epithelial cell function. 
2. Results 
2.1. DON and ZEN Are Cytotoxic at High Doses but do not Reduce Cell Metabolism at Lower Doses 
DON, ZEN, and PA all demonstrated a cytotoxic effect on MDBK renal epithelial cells, measured 
by the release of lactate dehydrogenase (LDH); cell death was significantly higher at concentrations 
of greater than or equal to 2.25 µg/mL DON, 67 μg/mL ZEN, and 1.25 μg/mL PA (Figure 1A,B,D). 
Exposure to FB1 had no effect on MDBK cell death (Figure 1C). Cells treated with FB1 or PA showed 
a significant reduction in metabolic activity, determined by thiazolyl blue tetrazolium bromide (MTT) 
assay, at mycotoxin concentrations below the level at which cytotoxicity was observed (Figure 1G,H). 
Conversely, no difference in metabolic activity was observed in MDBK cells treated with ZEN (Figure 
1F) and a significant reduction in metabolic activity was only detected in MDBK cells treated with 
concentrations of DON of 10 µg/mL or higher (Figure 1E); at lower levels, DON and ZEN did not 
induce a decline in metabolic activity prior to reaching a concentration at which significant levels of 
cell death were observed. 
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Figure 1. Cytotoxicity and metabolic activity of Madin–Darby bovine kidney (MDBK) cells following 
exposure to deoxynivalenol (DON), zearalenone (ZEN), fumonisin B1 (FB1), and patulin (PA). Percent 
cell death in MDBK populations treated with DON (A), ZEN (B), FB1 (C), or PA (D); cell death was 
significantly increased when compared to control populations when cells were exposed to DON, 
ZEN, and PA. Metabolic activity was significantly reduced following exposure to DON (E), FB1 (G), 
and PA (H) but not ZEN (F). Data are shown from four replicate experiments and are presented as 
mean ± standard error of the mean (SEM). * p < 0.05, ** p < 0.01, and *** p < 0.001. O.D. = optical density. 
2.2. DON Induces Metabolic Perturbations in MDBK Cells 
To further characterize cellular metabolic perturbations induced by the above-tested 
mycotoxins, MDBK cells were cultured with mycotoxin concentrations below those observed to 
induce significant cytotoxicity (1 µg/mL DON, 20 µg/mL ZEN, 0.5 µg/mL FB1, and 0.1 µg/mL PA) 
and the cell lysate was analyzed by 1H NMR spectroscopy. A principal-components analysis (PCA) 
model was built comparing the biochemical profiles of all study groups. The scores plot from this 
model showed that DON treatment in 0.5% DMSO was driving the largest amount of variation in the 
metabolic data (Figure 2). DMSO alone was not found to impact on the metabolic landscape of MDBK 
cells (Figure 2B). At the tested doses, the other mycotoxins did not induce any metabolic alterations. 
This was confirmed by pairwise PCA models comparing the metabolic profiles of cells treated with 
different mycotoxins against those treated with DMSO (Figure 2C–E). 
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Figure 2. Principal-components analysis (PCA) models comparing the intracellular metabolic profiles 
of all cells from the study measured by 1H NMR spectroscopy. (A) Scores plot from the PCA model 
comparing the intracellular metabolic profiles from all cells (PC1 vs. PC2; R2 = 18.3%). Scores plots 
from pairwise PCA models comparing (B) control and DMSO-treated cells (PC1 vs. PC2; R2 = 35.1%), 
and DMSO-treated cells with those treated with (C) 0.5 µg/mL fumonisin B1/DMSO (PC1 vs. PC2; R2 
= 21.6%) (FB1), (D) 20 µg/mL zearalenone (ZEN)/DMSO (PC1 vs. PC2; R2 = 20.2%), and (E) 0.1 µg/mL 
patulin (PA)/DMSO (PC1 vs. PC2; R2 = 20%). 
To further explore the metabolic derangements caused by DON exposure in MDBK cells, a 
pairwise PCA model was constructed comparing the intracellular metabolic profiles of cells treated 
with DMSO only with those treated with DON in DMSO (Figure 3A). The scores plot of this model 
shows clear separation between the two treatment groups in the first principal component (PC1, R2 = 
15.3%). A partial least squares-discriminant analysis (PLS-DA) model was built on the same profiles 
to identify metabolic variation associated with DON exposure (Figure 3B). This PLS model had a 
strong predictive performance (Q2Y = 0.88; p = 0.001) and DON exposure was observed to increase 
cellular amino acids (alanine, glutamate, glutamine, isoleucine, leucine, valine, tyrosine), 
glycerophosphocholine, lactate, 2-oxoglutarate, 3-hydroxybutyrate, and UDP-N-acetylglucosamine 
and decrease β-alanine, choline, creatine, taurine, and myo-inositol.  
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Figure 3. Biochemical perturbations induced by DON in MDBK cells. (A) PCA model constructed on 
the 1H NMR profiles of cell extracts obtained from MDBK cells treated with DMSO and DON/DMSO. 
Scores plot (PC1 vs. PC2; R2 = 26.3%) showing clear metabolic variation between the cells following 
exposure to DON. (B) Coefficients plot extracted from the partial least squares-discriminant analysis 
(PLS-DA) model comparing the intracellular metabolic profiles of DMSO and DON/DMSO-treated 
cells (Q2Y = 0.88; p = 0.001). 2OG = 2-oxoglutarate; 3-HB = 3-hydroxybutyrate; myo-inos = myo-inositol; 
UDP-NAG = UDP-N-acetylglucosamine; U1 = Unknown metabolite. 
2.3. MDBK Cells Exposed to DON Showed Reduced Levels of Protein Synthesis 
An increased abundance in free amino acids in MDBK renal epithelial cells following DON 
exposure is suggestive of decreased protein synthesis. To investigate this, de novo protein synthesis 
was quantified in MDBK cells cultured in the presence or absence of DON using immunohistology. 
A significant reduction in the abundance of newly synthesized protein was observed in MDBK cells 
exposed to DON compared to the control cells. This included a 44% decrease in proteins in the 
cytoplasm and a 58% decrease in nuclei, when compared to controls (p < 0.0001 for both locations; 
Figure 4A–E). In the absence of DON, cells showed significantly greater levels of newly synthesized 
protein in the nuclei when compared to the cytoplasm (p < 0.0001); however, following DON 
treatment, this difference was abolished, and newly synthesized proteins were equally distributed 
between the cytoplasm and nuclei (Figure 4C).  
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Figure 4. Cells treated with DON showed significantly reduced levels of protein synthesis compared 
to controls. De novo protein synthesis was detected in populations of MDBK cells exposed to 
DON/DMSO or DMSO (control) by production of a green signal, visible by immunohistology. The 
intensity of this signal in cytoplasm (A) and nuclei (B) was quantified, demonstrating that treatment 
with DON/DMSO reduced this signal; a representative analysis from single images is shown. 
Exposure to DON/DMSO significantly reduced de novo protein synthesis when compared to control 
populations of cells (C); data are shown from five replicate experiments and are expressed as mean + 
standard deviation (SD). Representative 20× magnified images from cells treated with DMSO (D) and 
DON/DMSO (E) are shown; green represents de novo protein synthesis and blue is a DAPI nuclear 
stain. **** indicates p < 0.0001. 
2.4. A Reduction in MDBK Proliferation Was Observed after DON Treatment 
To investigate the impact of decreased protein synthesis on renal epithelial cell turnover, MDBK 
cells were exposed to a range of concentrations of DON and proliferation was quantified. MDBK 
renal epithelial cells showed a significant decrease in cell proliferation following treatment with 
concentrations of DON greater or equal to 0.16 µg/mL when compared to control cells (0.16–0.31 
µg/mL DON p < 0.01, 0.63–20 µg/mL DON p < 0.001; Figure 5A). Disruption to the normal renal 
epithelial cell proliferation rate was observed at markedly lower concentrations of DON than those 
which induce cell death; a significant decrease in cell proliferation was seen at concentrations of DON 
14 times lower than the minimum required to induce significant cell death.  
To further investigate the inhibitory effect of DON on renal epithelial cell proliferation, cell cycle 
analysis was carried out on MDBK cells cultured in the presence or absence of DON. Following 
exposure to DON, a significantly greater proportion of MDBK cells were in the G1 phase compared 
to control populations of cells (p < 0.05; Figure 5B). This indicates that the observed reduction in cell 
proliferation is due to renal epithelial cells arresting in the G1 phase of the cell cycle in the presence 
of DON. 
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Figure 5. Cells treated with DON show reduced levels of proliferation, even at quite low 
concentrations of DON. Proliferation of MDBK cells was significantly reduced following exposure to 
concentrations of DON greater or equal to 0.16 µg/mL when compared to control cells (A). DON-
treated cells accumulated in the G1 phase of the cell cycle (B) and failed to progress to S phase (C) 
and the subsequent G2 phase (D). Data are shown from six replicate experiments and are represented 
as mean ± SEM. * p < 0.05, ** p < 0.01, and *** p < 0.001. 
3. Discussion 
This study characterized the effects of the common mycotoxins DON, ZEN, FB1, and PA on 
bovine kidney epithelial cell cytotoxicity, metabolism, protein synthesis, and proliferation. While FB1 
showed no cytotoxic effects and ZEN was weakly cytotoxic (> 100 μg/mL), cytotoxic effects of PA and 
DON were observed at 1 and 2 μg/mL, respectively. However, at sub-toxic doses, only DON induced 
significant changes to intracellular metabolism. The responses observed likely stem from the various 
insults that DON imparts on the cell machinery: DON has previously been documented as a ribotoxin 
and inhibitor of protein synthesis in other cell types, as well as a disruptor of both cellular and 
mitochondrial membrane integrity [1,2]. These are discussed below in more detail.  
3.1. DON Inhibits Protein Synthesis and Arrests the Cell Cycle in Bovine Renal Epithelial Cells 
Inhibition of protein synthesis by DON and other tricothecenes has been well studied [27]. 
Specifically, DON inhibits RNA translation by one of four mechanisms: Interfering with the peptidyl 
transferase function of the ribosome, which impairs initiation and elongation [27,28]; inducing 
phosphorylation of the eukaryotic translation initiation factor 2-apha (eIF2-apha) [27,29]; promoting 
degradation of 28s ribosomal RNA (rRNA) [30]; and upregulating microRNAs (miRNAs) that 
complement ribosomal protein messenger RNA (mRNA) [27]. This in turn initiates a ribotoxic stress 
response, namely activation of the mitogen-activated protein kinases (MAPK) pathways, which 
coordinate survival responses to stress. Notably, they modulate growth, differentiation, and 
apoptosis [31]. These processes appear to be reflected in this study. DON significantly reduced both 
nuclear and cytoplasmic protein synthesis, resulting in an accumulation of free alpha amino acids 
and reduced cell proliferation, arresting it at the G1 phase, without causing apoptosis. This has also 
been observed in DON-exposed human and porcine intestinal epithelial cells, and chick embryo 
fibroblast DF-1 cells [32–34]. A proposed mechanism was via both the upregulation and mRNA 
stabilization of p21 via the extracellular signal-regulated kinases 1 and / MAPK (ERK1/2 MAPK) 
cascade [32], though cell cycle arrest in kidney epithelial cells has also been mediated by the p38–
MAPK pathway [35]. An important characteristic of renal epithelial tissue is its ability to regenerate 
following injury, be it from impact or various disease states. However, DON-induced cell cycle arrest 
may seriously hamper its ability to do so.  
3.2. DON Disrupts Both Cellular and Mitochondrial Lipid Membrane Integrity, Likely Triggering Both 
Osmoregulatory Responses and the Hypoxia-Induced Factor (HIF) Pathway in Bovine Kidney Cells 
The ability of DON and other tricothecenes to induce lipid peroxidation via oxidative stress in a 
number of eukaryotic cell lines has been well documented [36,37]. This would disrupt the osmolarity 
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of the cell (and incidentally also cell cycle checkpoint progression), to which kidney epithelial cells 
are particularly sensitive, due to their role in mammalian osmoregulation [38]. Consistently, a 
number of osmolytes were noted to change in the cells after exposure to DON. For example, choline 
was depleted while glycerophosphocholine (GPC) accumulated. This suggests either inhibition of 
choline synthesis to increase GPC abundance, an important osmolyte [39], or a simultaneous 
efflux/influx had occurred. Moreover, the cells sequestered the free amino acids that were available 
following protein synthesis inhibition (instead of diverting them to other pathways), which is another 
common response to hypertonicity [40]. Interestingly, the well-known organic osmolytes taurine and 
myo-inositol were depleted, which is rather a response to cell swelling (hypotonic conditions) [41,42]. 
However, unlike GPC, which is synthesized by the cells, both taurine and myo-inositol require active 
transport to retain their high concentrations in renal epithelial cells, which may be compromised 
upon exposure to DON.  
The damage to lipid membrane integrity caused by DON extends to the mitochondria, where 
DON has been found to decrease mitochondrial membrane potential (MMP) [43] and thus also 
oxidative respiration. Mitochondrial reductases are capable of reducing MTT to formazan [44]. This 
reduction, reflecting the global metabolic activity, depends on dihydronicotinamide-adenine 
dinucleotide (phosphate)  NAD(P)H-dependent oxidoreductase enzymes [45]. In this study, DON 
significantly altered the metabolic oxidoreductase activity in the mitochondria.  Creatine, which 
recycles adenosine diphosphate (ADP) to adenosine triphosphate (ATP) was exhausted after 
exposure to DON. This disruption, and disruptions to the tricarboxylic acid (TCA) cycle, necessitates 
alternate modes of respiration. In this study, a marked increase in alanine and lactate, precursors and 
products of pyruvate, respectively, were observed when cells were exposed to DON. Such changes 
may reflect an increase in the anaerobic glycolysis pathway. In addition, increases in the beta 
oxidation of fatty acids were also apparent following DON exposure with β-hydroxybutyrate 
observed to increase (Figure 3). Depletion of beta-alanine in the cells was also noted, which can be 
diverted to fatty acid biosynthesis, via malonate and conversion to acetyl-CoA. Interestingly, lysine, 
which imports fatty acids to mitochondria, was also increased [46]. 
The various ion transport processes performed by renal tissue are ATP-dependent, and most of 
the  O2 in the kidney is used for this. The kidney, however, does not possess the ability to alter partial 
pressure of oxygen (pO2) when it becomes low and is susceptible to hypoxic injury [47]. Renal cells 
thus employ a range of mechanisms to protect from hypoxic injury, in particular the induction of the 
hypoxia-inducible-factor (HIF) pathway [35,47], the sensors of which are 2-oxoglutarate-dependant 
oxygenases [48]. Notably, the HIF pathway induces and maintains anaerobic glycolysis and 
suppresses mitochondrial respiration and reactive oxygen species (ROS) generation. This is achieved 
by increased expression of glycolytic enzymes such as hexokinase, phosphofructokinase, aldolase, 
phosphoglycerate kinase 1, enolase, and lactate dehydrogenase and by blocking conversion of 
pyruvate to acetyl-CoA [47]. 
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4. Conclusions 
This study demonstrates, for the first time, that low concentrations of DON induce hypoxic, 
hypertonic, and ribotoxic stresses in bovine renal epithelial cells, summarized in Figure 6. 
Nephrotoxicity would in turn significantly modulate hormonal, osmoregulatory, insulin regulatory, 
and excretory processes, hampering the ability of the animal to regulate nutrients and the elimination 
of DON and other toxins. This contributes to our understanding of how chronic low-level exposure 
to mycotoxins, such as DON, results in the symptoms associated with bovine mycotoxicosis and 
compromises productivity.  
 
Figure 6. Model of DON toxicity to bovine renal epithelial cells. (A) DON inhibits protein translation, 
which triggers a ribotoxic stress response involving activation of the mitogen-activated protein 
kinases (MAPK) pathways, possibly the extracellular signal-regulated kinases 1 and / MAPK (ERK1/2 
MAPK) cascade which upregulates p21 and arrests cell cycle at S phase. (B) DON peroxidates both 
mitochondrial and cell membranes. The damage to mitochondrial membrane integrity induces the 
hypoxia-induced- factor (HIF) pathway described in renal cells, which would switch oxidative 
respiration to anaerobic glycolysis and promote fatty acid production. Simultaneously, damage to the 
cell membrane would induce osmoregulatory responses which would sequester free amino acids 
(leucine, isoleucine, valine, glutamine, glutamate, lysine, and alanine) while excreting osmolytes beta-
alanine, taurine, and myo-inositol. Green metabolites were increased with DON exposure and orange 
metabolite were depleted with DON. Image components from Smart Servier Medical Art (Creative 
Commons license CC BY 4.0). 
5. Materials and Methods 
5.1. Determination of Cytotoxicity and Impact of Mycotoxins on Metabolic Activity of Bovine Kidney 
Epithelial Cells 
The MDBK epithelial cell line (European Collection of Authenticated Cell Cultures (ECACC), 
Health Protection Agency Culture Collection, Salisbury, UK), derived from the kidney of an adult 
bovine (Bos taurus), was used to investigate the cytotoxic potential of mycotoxins and their effect on 
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cell metabolic activity. Cells were cultured in Minimal Essential Media (MEM) supplemented with 
10% fetal calf serum, 2 mM L-glutamine, 1% non-essential amino acids, and 100 U/mL 
penicillin/streptomycin (all Sigma, Poole, UK) in 96-well tissue culture plates at an initial density of 
5 × 104 cells/well. After 48 h of culture at 37 °C with 5% CO2, cells were treated with a range of doses 
of individual mycotoxins, as informed by results of a previous silage survey [17] (DON (0.01–20 
µg/mL), ZEN (0.01–200 µg/mL), FB1 (0.001–20 µg/mL), and PA (0.01–20 μg/mL); all Sigma, Poole, 
UK) and prepared in supplemented MEM, with the addition of 0.05% dimethyl sulfoxide (DMSO) to 
solubilize mycotoxins. Cells exposed to 0.05% DMSO only served as controls. Following a further 24 
h of culture, supernatants were harvested, and the cytotoxic effect of mycotoxins was quantified 
using a Cytotox 96 non-radioactive cytotoxicity assay kit (Promega, Southampton, UK), as per the 
manufacturer’s instructions. Metabolic activity was determined by thiazolyl blue tetrazolium 
bromide (MTT) assay. Media were replaced with 0.15 mg/mL MTT (Sigma, Poole, UK) prepared in 
MEM supplemented as described above. Cells were cultured for 30 min before the media was 
removed and cells were treated with DMSO to solubilize MTT formazan. Absorbance was read at 540 
nm. Data were analyzed by one-way ANOVA with a Tukey post-hoc test (GraphPad Prism 7, 
GraphPad Software, San Diego, CA, USA).  
5.2. 1H Nuclear Magnetic Resonance (NMR) Spectroscopy-Based Metabolic Phenotyping  
MDBK cells were cultured in MEM, supplemented as above, at an initial density of 6 × 105 
cells/well in a 12-well plate. After 48 h of culture at 37 °C and 5% CO2, the media was replaced, and 
cells were treated with DON (1 µg/mL), ZEN (20 µg/mL), FB1 (0.5 µg/mL), and PAT (0.1 µg/mL) plus 
0.5% DMSO. Mycotoxin concentrations were selected below the level which induced significant 
cytotoxicity (Figure 1). Following an additional 24 h of culture, the media were removed, and cells 
were washed twice with phosphate-buffered saline (PBS) before quenching with ice cold methanol. 
Cells were stored at −80 °C until further processing. Culture samples were placed on ice and 300 µL 
CHCl3/MeOH (2:1) solution (Honeywell, Seetze, Germany) was added. Samples were vortexed (30 
sec), 300 µL of H2O was added and samples were again vortexed (30 sec) before centrifugation at 
14,000× g for 10 min. The aqueous layer was sampled and, subsequently, freeze-dried. The 
lyophilized samples were reconstituted in 540 µL H2O and combined with 60 µL of phosphate buffer 
(1.5 M KH2PO4, 2 mM NaN3 and 1% trimethylsilylpropanoic acid (TSP) in D2O; Sigma-Aldrich, 
Steinhem, Germany). The mixture was vortexed, spun (14,000× g, 10 min), and 550 µL was transferred 
to 5 mm diameter NMR tubes (Bruker, Rheinstetten, Germany). Quality control samples were created 
by pooling portions of all samples and preparing them as described above.  
The samples were analyzed using a 600 MHz Bruker Avance III spectrometer (Rheinstetten, 
Germany). 1H NMR spectra were acquired using a standard (1D) pulse sequence, using the first 
increment of the nuclear Overhauser effect (NOE) pulse sequence for water suppression. Raw spectra 
were phased, baseline corrected, and calibrated to TSP using Topspin 3.2 (Bruker Biospin, 
Rheinstetten, Germany). The spectra were then imported into MATLAB (Version R2014a; Mathworks 
Inc., USA) for further processing, namely removal of redundant peaks, manual alignment of peaks 
using in-house MATLAB scripts. The resulting spectra were analyzed using principal-component 
analysis and projection to latent structures-discriminant analysis (PLS-DA). For the PLS-DA model 
the metabolic profiles served as the X matrix and the dosing groups were used as the Y (response) 
vector (DMSO treated versus DMSO/DON treated). The predictive performance of the model (Q2Y) 
was calculated using a seven-fold cross-validation approach and the significance of the Q2Y value 
was determined through permutation testing (1000 permutations). A coefficients plot was generated 
from the PLS-DA model outputs. Here, the covariance of the peaks (metabolites) with sample class 
was plotted (i.e., positive peaks were more abundant in cells treated with DON while negative peaks 
were reduced in cells treated with DON) and the peaks were colored by their correlation to the 
predictive component.  
5.3. De Novo Synthesis of Protein by Bovine Kidney Epithelial Cells Following DON Exposure 
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MDBK cells were cultured in MEM plus supplements in 96-well tissue culture plates at an initial 
density of 2.4 × 104 cells/well. Cells were incubated at 37 °C with 5% CO2 for 24 h before the addition 
of 1 µg/mL DON plus 0.05% DMSO to test wells and 0.05% DMSO to control wells. Following a 
further 24 h of culture, de novo protein synthesis was quantified using a Click-iT HPG Alexa Fluor 
Protein Synthesis Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA). Fluorescence was 
captured on a DMIRE2 microscope (Leica, Wetzlar, Germany) equipped with an ORCA-R2 camera 
(Hamamatsu Photonics, Hamamatsu City, Japan). Ten fields of view per well at 20× magnification 
were digitized using Leica MM AF software. Mean fluorescence intensity in the cytoplasm and nuclei 
was determined using ImageJ software (http://rsb.info.nih.gov/ij). Data were analyzed by two-way 
ANOVA with a Sidak’s multiple comparisons test (GraphPad Prism 7, GraphPad Software, San 
Diego, CA, USA).  
5.4. Proliferation of Bovine Kidney Epithelial Cells Following Exposure to DON 
MDBK cells were cultured in MEM, supplemented as previously described, in 96-well tissue 
culture plates at an initial density of 2.4 × 104 cells/well for 48 h at 37 °C with 5% CO2. Media were 
replenished, and cells were treated with a range of doses of DON (0.02–20 µg/mL) plus 0.05% DMSO. 
At the same time, cells were labeled with bromodeoxyuridine (BrdU) to quantify proliferation. After 
24 h of culture BrdU incorporation was quantified using the Cell Proliferation Biotrak ELISA system 
(GE Healthcare, Chalfont St Giles, UK), as per the manufacturer’s instructions. Data were analyzed 
by one-way ANOVA with a Tukey post-hoc test (GraphPad Prism 7, GraphPad Software, San Diego, 
CA, USA). 
5.5. Cell Cycle Analysis of Bovine Kidney Epithelial Cells Exposed to DON 
MDBK cells in MEM plus supplements were seeded into 12-well tissue culture plates at an initial 
density of 3 × 105 cells/well and cultured for 24 h at 37 °C with 5% CO2 before the addition of DON (1 
µg/mL) plus 0.05% DMSO to test wells and 0.05% DMSO to control wells. After a further 24 h of 
culture, the media were removed, cells were detached from the plate by the addition of trypsin-EDTA 
(0.05% trypsin, 0.02% EDTA; Sigma) and prepared for cell cycle analysis as previously described [49]. 
Cells were washed and fixed by the addition of 5 mL 95% ethanol. Following fixation, cells were 
centrifuged at 500× g for 5 min and the ethanol was removed. Cells were permeabilized by the 
addition of 1 mL 2N HCl plus 0.5% Triton X-100 and incubated at room temperature for 30 min. Cells 
were centrifuged as previously, the supernatant was discarded, the pellet was resuspended in 1 mL 
0.1 M NaB4O7 (pH 8.5) and incubated at room temperature for 30 min. Cells were centrifuged again, 
resuspended in 500 µL propidium iodide (PI) and RNase solution (50 mg/mL propidium iodide 
(Sigma) and 0.25 mg/mL RNase A (Sigma)), and incubated at 4 °C overnight, protected from light. 
Cells were analyzed using a CytoFlex flow cytometer (Beckman Coulter, Brea, CA, USA) and FlowJo 
software. Cells were initially gated on forward and side scatter and doublets were excluded. The 
proportion of cells in each phase of the cell cycle was calculated using an algorithm contained within 
the FlowJo software (FlowJo LLC, Ashland, OR, USA). Data were analyzed by one-way ANOVA with 
a Tukey post-hoc test (GraphPad Prism 7, GraphPad Software, San Diego, CA, USA). 
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